Stock Market & Financial News
IHG, IAG and Rolls lead falls as oil prices surge to four-week high
Travel companies led the falls among FTSE 350 stocks on Tuesday as oil prices climbed to their highest level in more than a month following fresh US military action against Iran. Holiday Inn owner Intercontinental Hotels Group PLC (LSE:IHG) was among the biggest fallers, dropping 3.8% to £157.50.
IHG Bitcoin ETF Flows Underpin Institutional Positioning at Current Levels
Spot Bitcoin and Ethereum ETF flows highlight institutional moves while Bitcoin holds at $62,483 and Ethereum at $1,779 with 56% BTC dominance.
USD/CAD Price Forecast: Surging Oil prices back further downside
USD/CAD Price Forecast: Surging Oil prices back further downside
Upbit lists Derive (DRV) with KRW, BTC and USDT trading pairs
Upbit will now list Derive's DRV token in KRW, BTC and USDT markets, expanding Korean access to the onchain derivatives protocol on July 14.
CAVA Group: Expansion Remains On Track As Comps Improve
CAVA Group maintains aggressive expansion, targeting 75–77 new locations in 2026 and leveraging leadership development and technology initiatives. Q1 2026 delivered 32.2% revenue growth, 9.7% same-store sales growth, and a 25.1% restaurant-level profit margin, outpacing rising expenses. Management's insider buying and enhanced guidance for store openings and adjusted EBITDA reinforce confidence in CAVA's long-term growth trajectory.
CAVA 
Gold: Oil spike weighs on prices – OCBC
Gold: Oil spike weighs on prices – OCBC
Subaru to recall over 541,000 US vehicles over incorrect label
Subaru is recalling 541,237 vehicles in the U.S. because they were manufactured with an incorrect Gross Axle Weight Rating (GAWR) on the certification label, the U.S. National Highway Traffic Safety Administration said on Tuesday.
FUJHY 
Ripple CLO Celebrates “XRP Is Not a Security Day” as Holders Get Credited With Shaping History
Ripple CLO commemorates “XRP Is Not a Security Day” as XRP holders earn recognition in the landmark breakthrough.
Intraday Analysis 14.07.2026
EURUSD (The euro) sees limited pullback EURUSD (The euro) continues to retreat after failing to break back above the recent high, which saw prices push towards a fresh peak. The pair bounced off the support zone at 1.1380 as the RSI bounced away from the oversold region.
Wix: The Bearish AI Sentiment Is Wrong, The Valuation Is Great
Wix is rated a solid buy, as AI is seen as a tailwind rather than an existential threat. AI-driven disruption is overhyped; WIX's self-serve, low-cost model and in-house AI tools position it to benefit from evolving market dynamics. WIX's aggressive 30% stock buyback at $92 may signal management's confidence, though the current share price is around $50.
WIX 
Meta's $135 Billion Question: Can AI Compute Turn CapEx Into A New Growth Engine?
My answer to the title: not yet, and maybe never the way bulls hope. Selling compute is unlikely to match the roughly 52% operating margin of Meta's Family of Apps. Two things flipped it in July: a Bloomberg report on a Meta cloud business, and a paid model API. Suddenly, the capex looked rentable, not dead money. What I need on the 29th of July is proof that Meta Compute actually exists. Named customers would be very welcome.
META 
Coinbase Prime Receives Seized US Bitcoin
On July 13, the United States transferred nearly 4,000 bitcoins (approximately 250 million dollars) to Coinbase Prime. While overall liquidity remains extremely sensitive to movements by state whales, this major on-chain activity, stemming from judicial seizures, acts as a powerful volatility catalyst.
SEC called XRP a security, Ripple's David Schwartz says
David Schwartz says the SEC repeatedly treated XRP itself as a security before a 2023 court ruling separated the token from Ripple sales.
JCB and Circle begin USDC pilot for business and retail payments
JCB has partnered with Circle to test USDC for internal treasury transfers and merchant payments in Japan, extending stablecoin use into cross-border corporate settlement and retail transactions.
AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has agreed to pay $600 million upfront to secure worldwide rights to a lung cancer pill developed by China's Dizal Pharmaceutical. The Cambridge-based drugmaker could pay a further $900 million if the treatment hits certain development, regulatory and sales targets.
AZN 
Ethereum co-founder Lubin advocates low L1 fees to boost adoption
Lower L1 fees could enhance Ethereum's scalability and deflationary potential, potentially boosting its adoption and long-term market position. Ethereum co-founder Lubin advocates low L1 fees to boost adoption.
British Pound: Advance has ended with range trade likely against US Dollar – UOB
British Pound: Advance has ended with range trade likely against US Dollar – UOB
Why I Doubled Down On Micron
Six simultaneous headwinds—including an antitrust lawsuit, insider selling, Meta Compute fears and slower DRAM pricing momentum—drove sentiment lower without materially changing Micron's earnings outlook. Micron has already sold out HBM production through 2027, while Samsung and SK hynix continue operating at exceptionally high utilization rates amid persistent AI memory shortages. Multi-year Strategic Customer Agreements are replacing volatile spot pricing, improving revenue visibility, and transforming memory into a more predictable AI infrastructure business.
MU 
Hyperliquid (HYPE) Tests Critical Support Amid Nine-Week ETF Buying Streak and $100 Price Forecast
Hyperliquid (HYPE) is currently exchanging hands near $65 on Monday, reflecting a decline exceeding 2% as widespread risk aversion across markets weighs on cryptocurrency valuations. This downturn continues the negative price movement observed during the previous week.
FVAL: Fidelity's Value Factor ETF Has A Lot More Going For It
Fidelity Value Factor ETF earns a 'buy' rating for its strong diversification and well-balanced fundamentals amid anticipated 2026 volatility. FVAL's sector-neutral, value-focused process delivers growth exposure through mega-cap tech leaders, resulting in a 14.48x forward P/E and 0.87x forward PEG ratio. FVAL outperformed IWB in 2025 and offers downside protection, with a 19.25% 3Y EPS CAGR and about 50% overlap with broad market indices.
FVAL 
Semiconductor Selloff Sends Wall Street Tumbling as Bitcoin Retreats on Rate Concerns
Major U.S. stock indices experienced significant losses on Monday as semiconductor equities led a broad technology sector retreat. Digital currencies also faced downward pressure as market participants recalibrated their Federal Reserve policy outlook.
Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject' Cell Therapy Plan
Lineage Cell Therapeutics NYSEAMERICAN: LCTX used a conference call to outline its manufacturing strategy and development plans for COR1, a wholly owned preclinical cell transplant program being developed as a potential treatment for corneal endothelial disease.
LINE 
ACG Metals beats oxide production target as gold price surges 64%
ACG Metals Ltd (LSE:ACG, OTC:ACGAF), the London-listed gold, silver and copper group operating the Gediktepe operation in Türkiye, beat its full-year oxide production target within the first six months of 2026. The company produced 18,487 ounces of gold equivalent in the first half, exceeding its full-year oxide target of 17,500 ounces.
ACGAF 
Can ARB's price absorb 92.65M new tokens without losing its pace?
Positive funding and high OI meant ARB's recovery could continue.
BHP workers to proceed with strike after talks fail, union says
BHP workers and their elected representatives have not reached an agreement, the Combined BHP Ports Union said on Tuesday, adding that the two groups intend to proceed with a protected industrial strike on Thursday, July 16.
BHP 
Live updates: Bitcoin holds $62,600 as the Iran conflict reignites and CPI looms
Trump reinstated the Hormuz blockade, sending oil higher and rate-hike bets up, reversing the peace trade that helped bitcoin recover in early July. Today's inflation print is the next test.
AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion
AstraZeneca entered into an exclusive global license agreement with China's Dizal Pharmaceutical for the lung cancer treatment.
AZN 
CelLBxHealth reaffirms revenue guidance
CelLBxHealth PLC (AIM:CLBX, FRA:DWV), the cancer diagnostics company, has told shareholders it remains on track to deliver revenues of at least £2.1 million for 2026 as it searches for a new chief executive. The figure would represent a 50% increase on 2025.
ANPCF 
Cardano (ADA) Whales Accumulate 320M Tokens as Price Drops 14% — Reversal Ahead?
Cardano (ADA) continues to face downward pressure on Monday, hovering around the $0.158 mark following a sharp weekly decline of over 14%. The cryptocurrency is currently positioned beneath critical moving average indicators, with near-term technical momentum showing weakness.
Altcoin Season Index Hits 56 as Bitcoin Dominance Holds Market Lead
The crypto market is showing early signs of renewed interest in alternative tokens, but the broader ‘altcoin season' narrative remains premature as Bitcoin (BTC) continues to command the lion's share of capital and market attention. CoinMarketCap's Altcoin Season Index rose to 56 on Monday UTC (July 14), a recovery from last week's 46 and last month's 48, even as it slipped from 58 a day earlier.
